People · Operator
Named in public records as an officer, director or promoter · active 2020–2021 · Proptech / Real Estate, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| USRC Houston Newco Home, LLC | — | Proptech / Real Estate | Seed | $2.6M | $27.9M | 2020 |
| USRC Compton, LLC | — | Other Health Care | Seed | $1.4M | $27.4M | 2021 |
| USRC North Flushing, LLC | — | Other Health Care | Seed | $1.2M | $20.5M | 2021 |
| USRC New Milford, LLC | — | Other Health Care | Seed | $1.1M | $20.0M | 2021 |
| Ulster Dialysis Partners, LLC | — | Other Health Care | Pre-Seed | $930K | $27.6M | 2020 |
| USRC McKinney, LLC | — | Other Health Care | Pre-Seed | $542K | $16.1M | 2020 |
| USRC Garland, LLC | — | Other Health Care | Pre-Seed | $434K | $12.9M | 2020 |
| USRC Bluebonnet, LLC | — | Other Health Care | Pre-Seed | $332K | $9.1M | 2020 |
| USRC FWRG-Keller, LLC | — | Other Health Care | Pre-Seed | $226K | $7.0M | 2020 |
| USRC Bluebonnet Home, LLC | — | Proptech / Real Estate | Pre-Seed | $111K | $1.4M | 2020 |
Mike L Huguelet at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mike L Huguelet on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Thomas L. Weinberg | 10 | 48 |
| James Shelton | 6 | 40 |
| Mary Dittrich | 4 | 12 |
| James L Shelton | 3 | 4 |
| Geethanjali L Ramamurthy | 3 | 3 |
| Koshy L Abraham | 3 | 3 |
| Mary L Dittrich | 2 | 12 |
| Joseph Brunink | 2 | 6 |
| Yugandhar L Chimata | 2 | 3 |
| Robert L Santelli | 2 | 3 |
| Joseph L Brunink | 2 | 2 |
| Oladapo L Afolabi | 2 | 2 |
| James D. Shelton | 1 | 23 |
| Mark Caputo | 1 | 7 |
| Joseph D. Brunink | 1 | 1 |
| Oladapo L. Alfolabi | 1 | 1 |
| Luani K Lee | 1 | 1 |
| Wei Y Sun | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.